Investor Presentation via Investor Meet Company
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for oncology, gene therapy and vaccines, is pleased to announce that Nigel Theobald (CEO) and Paul Murray (Nanogenics) will provide an update following the Company's acquisition of Nanogenics via a live presentation on the Investor Meet Company platform on 16 October 2023 at 2.00pm BST.
Investors can sign up to Investor Meet Company for free and add to meet N4 Pharma Plc via:
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.